The lipoprotein lipase gene in combined hyperlipidemia: Evidence of a protective allele depletion

Lipids in Health and Disease

Volumn 5, Issue , 2006, Pages

  Wung, Shu Fen ^a   Kulkarni, Medha V ^b   Pullinger, Clive R ^b   Malloy, Mary J ^b   Kane, John P ^b   Aouizerat, Bradley E ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; ALLELES; FEMALE; GENE DELETION; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33747199044     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-5-19     Document Type: Article

References (55)

1. Farmer JA, Gotto AMJ: Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis 2002, 44(6):415-428.
2. Wilson PW, Castelli WP, Kannel WB: Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987, 59(14):91G-94G..
3. Lusis AJ: Atherosclerosis. Nature 2000, 407(6801):233-241.
4. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3(2):213-219.
5. Hokanson JE: Functional variants in the lipoprotein lipase gene and risk cardiovascular disease. Curr Opin Lipidol 1999, 10(5):393-399.
6. Wittrup HH, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A: Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 2002, 165(1):119-126.
7. Fisher RM, Humphries SE, Talmud PJ: Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 1997, 135(2):145-159.
8. Otarod JK, Goldberg IJ: Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr Atheroscler Rep 2004, 6(5):335-342.
9. Taskinen MR, Nikkila EA: High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man - evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clin Chim Acta 1981, 112(3):325-332.
10. Clee SM, Bissada N, Miao F, Miao L, Marais AD, Henderson HE, Steures P, McManus J, McManus B, LeBoeuf RC, Kastelein JJ, Hayden MR: Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res 2000, 41(4):521-531.
11. Malloy MJ, Kane JP: A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 2001, 47:111-136.
12. Rapp JH, Harris HW, Hamilton RL, Krupski WC, Reilly LM, Ehrenfeld WK, Stoney RJ, Goldstone J, Kane JP: Particle size distribution of lipoproteins from human atherosclerotic plaque: a preliminary report. J Vasc Surg 1989, 9(1):81-88.
13. Fojo SS, Brewer HB: Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992, 231(6):669-677.
14. Hayden MR, Ma Y: Molecular genetics of human lipoprotein lipase deficiency. Mol Cell Biochem 1992, 113(2):171-176.
15. Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P: Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6. Ann Genet 2001, 44(1):25-32.
16. Kobayashi J, Nishida T, Ameis D, Stahnke G, Schotz MC, Hashimoto H, Fukamachi I, Shirai K, Saito Y, Yoshida S: A heterozygous mutation (the codon for Ser447 - a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Commun 1992, 182(1):70-77.
17. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ: Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998, 18(4):526-534.
18. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR: Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1996, 1302(2):159-166.
19. Gagne SE, Larson MG, Pimstone SN, Schaefer EJ, Kastelein JJ, Wilson PW, Ordovas JM, Hayden MR: A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 1999, 55(6):450-454.
20. Ross CJ, Liu G, Kuivenhoven JA, Twisk J, Rip J, van Dop W, Excoffon KJ, Lewis SM, Kastelein JJ, Hayden MR: Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation. Arterioscler Thromb Vasc Biol 2005, 25(10):2143-2150.
21. Rader DJ: Gain-of-function mutations and therapeutic implications: lipoprotein lipase S447X to the rescue. Arterioscler Thromb Vasc Biol 2005, 25(10):2018-2019.
22. Strauss JG, Frank S, Kratky D, Hammerle G, Hrzenjak A, Knipping G, von Eckardstein A, Kostner GM, Zechner R: Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J Biol Chem 2001, 276(39):36083-36090.
23. Aouizerat BE, Allayee H, Bodnar J, Krass KL, Peltonen L, de Bruin TW, Rotter JI, Lusis AJ: Novel genes for familial combined hyperlipidemia. Curr Opin Lipidol 1999, 10(2):113-122.
24. Eurlings PM, van der Kallen CJ, Geurts JM, van Greevenbroek MM, de Bruin TW: Genetic dissection of familial combined hyperlipidemia. Mol Genet Metab 2001, 74(1-2):98-104.
25. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG: Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973, 52(7):1544-1568.
26. Nikkila EA, Aro A: Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973, 1(7810):954-959.
27. Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI: Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am J Med 1973, 54(2):148-160.
28. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich POJ: Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A 1980, 77(1):604-608.
29. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J: Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 1993, 13(7):1110-1118.
30. Austin MA, Brunzell JD, Fitch WL, Krauss RM: Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990, 10(4):520-530.
31. de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991, 11(2):298-306.
32. Babirak SP, Brown BG, Brunzell JD: Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 1992, 12(10):1176-1183.
33. Seed M, Mailly F, Vallance D, Doherty E, Winder A, Talmud P, Humphries SE: Lipoprotein lipase activity in patients with combined hyperlipidaemia. Clin Investig 1994, 72(2):100-106.
34. Campagna F, Montali A, Baroni MG, Maria AT, Ricci G, Antonini R, Verna R, Arca M: Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia. Metabolism 2002, 51(10):1298-1305.
35. de Bruin TW, Mailly F, van Barlingen HH, Fisher R, Castro Cabezas M, Talmud P, Dallinga-Thie GM, Humphries SE: Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. Eur J Clin Invest 1996, 26(8):631-639.
36. Hoffer MJ, Bredie SJ, Snieder H, Reymer PW, Demacker PN, Havekes LM, Boomsma DI, Stalenhoef AF, Frants RR, Kastelein JJ: Gender-related association between the -93T->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia. Atherosclerosis 1998, 138(1):91-99.
37. Nevin DN, Brunzell JD, Deeb SS: The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 1994, 14(6):869-873.
38. Reymer PW, Groenemeyer BE, Gagne E, Miao L, Appelman EE, Seidel JC, Kromhout D, Bijvoet SM, van de Oever K, Bruin T, et al.: A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 1995, 4(9):1543-1549.
39. Ledmyr H, Karpe F, Lundahl B, McKinnon M, Skoglund-Andersson C, Ehrenborg E: Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 2002, 43(1):51-58.
40. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM: Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 2000, 148(2):337-343.
41. Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenson GS: Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study. Atherosclerosis 2001, 159(2):367-373.
42. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart JC, et al.: Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l'Infarctus du Myocarde. J Lipid Res 1995, 36(10):2141-2146.
43. Kuivenhoven JA, Groenemeyer BE, Boer JM, Reymer PW, Berghuis R, Bruin T, Jansen H, Seidell JC, Kastelein JJ: Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol 1997, 17(3):595-599.
44. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG: Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 1999, 99(22):2901-2907.
45. Zhang Q, Cavanna J, Winkelman BR, Shine B, Gross W, Marz W, Galton DJ: Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin Genet 1995, 48(6):293-298.
46. Senti M, Bosch M, Aubo C, Elosua R, Masia R, Marrugat J: Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene. The REGICOR investigators. Atherosclerosis 2000, 150(1):135-141.
47. Gagne E, Genest JJ, Zhang H, Clarke LA, Hayden MR: Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb 1994, 14(8):1250-1257.
48. Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, Pullinger CR, Malloy MJ, Kane JP: Genetic analysis of a polymorphism in the human apolipoprotein A-V gene: effect on plasma lipids. J Lipid Res 2003, 1:1.
49. Kane JP, Aouizerat BE, Luke MM, Shiffman D, Iakoubova O, Liu D, Rowland CM, Catanese JJ, Leong DU, Lau KF, Louie JZ, Tong CH, McAllister LB, Dabby LF, Ports TA, Michaels AD, Zellner C, Pullinger CR, Malloy MJ, Devlin JJ: Novel Genetic Markers For Structural Coronary Artery Disease, Myocardial Infarction, And Familial Combined Hyperlipidemia: Candidate And Genome Scans Of Functional SNPS. Proceedings of the International Symposium on Arteriosclerosis 2004:309-312.
50. Joshi AV, Day D, Lubowski TJ, Ambegaonkar A: Relationship between obesity and cardiovascular risk factors: findings from a multi-state screening project in the United States. Curr Med Res Opin 2005, 21(11):1755-1761.
51. Evans V, Kastelein JJ: Lipoprotein lipase deficiency - rare or common? Cardiovasc Drugs Ther 2002, 16(4):283-287.
52. Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP: Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995, 95(3):1225-1234.
53. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34(9):1345-1353.
54. Warnick GR, Benderson J, Albers JJ: Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28(6):1379-1388.
55. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ: Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. Jama 1990, 264(23):3007-3012.